Galmed Pharma (GLMD) Tops Q2 EPS by 5c

Galmed Pharma (NASDAQ: GLMD) reported Q2 EPS of ($0.33), $0.05 better than the analyst estimate of ($0.38).

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Oracle raises full year profit guidance, stock rises after hours
• RH shares jump after second quarter beat